Advancing the Science, Intervening Early and Seeking Cures — Gastrointestinal Cancers

The mission of the Mayo Clinic Cancer Center Gastrointestinal Program (GI Program) is to advance our knowledge of the pathogenesis, diagnosis, prevention, prognosis and treatment of gastrointestinal malignancies to reduce the incidence, increase survival, and improve the quality of life of individuals affected by GI diseases. The program has three investigative themes:

• Mechanisms of Carcinogenesis and Tumor Biology
• Risk Stratification and Early Detection
• Therapy and Novel Interventions

These themes represent the collaborative productivity of investigators and faculty engaged in conquering cancer.

Robust and comprehensive, the GI Program comprises four core disease categories: esophagus, pancreas, hepatobiliary, and lower gastrointestinal and includes clinical research activities in a total of eight different disease sites — esophagus, gastric, colorectal, anus neuroendocrine, pancreas, liver, bile duct, and small bowel. Each of these areas is highly organized into scientific programs that work closely with clinical areas to conduct research most relevant to patients and those at risk for gastrointestinal cancers.

Read More